Summary
Exact Sciences, is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
Deals Overview
Senior Management
Kevin Conroy
Chairman and CEO
Jeffrey Elliott
CFO
Scott Coward
General Counsel
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite